🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the efficacy and tolerability of th...
Status
Completed
Location
Vienna General Hospital
Start Date
2014-10
Trial ID
NCT02231762
Treatments Being Tested
Objectives: To determine maximum tolerated dose of farnesyl transferase in...
Status
Completed
Location
Duke University Health System
Start Date
2005-10
Trial ID
NCT00612651
Treatments Being Tested
ARISTOCRAT is a phase II, multi-centre, double-blind, placebo-controlled, r...
Status
Recruiting
Location
Glan Clwyd Hospital
Start Date
2023-02-03
Trial ID
NCT05629702
Treatments Being Tested
This study is a prospective single-center clinical study, which aims to obs...
Status
Recruiting
Location
Beijing Sanbo Brain Hospital
Start Date
2020-10-28
Trial ID
NCT04501718
Treatments Being Tested
Glioblastomas (GBMs) are the most common malignant primary brain tumors. De...
Status
Completed
Location
Institut Catalá de Oncología Badalona/Hospital Germans Trias i Pujol
Start Date
2018-03-15
Trial ID
NCT03466450
Treatments Being Tested
This study was conducted to evaluate the efficacy and safety of depatuxizum...
Status
Completed
Location
Lucile Packard Children's Hosp /ID# 153678
Start Date
2015-02-17
Trial ID
NCT02343406
Treatments Being Tested
This clinical trial is a rollover study designed to provide continued acces...
Status
Recruiting
Location
Kaohsiung Medical University Chung-Ho Memorial Hospital
Start Date
2026-04-20
Trial ID
NCT07569042
Treatments Being Tested
The primary purpose of this study is to compare the efficacy of AZD6244 (AR...
Status
Completed
Location
Research Site
Start Date
2006-07
Trial ID
NCT00338130
Treatments Being Tested
Currently,6 cycles of Temozolomide adjuvant chemotherapy after concurrent r...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2020-09-11
Trial ID
NCT04547855
Treatments Being Tested
MBM-02 (Tempol) is an HIF-1 and HIF-2 inhibitor that is being tested as an ...
Status
Unknown
Location
Georgetown
Start Date
2021-06-01
Trial ID
NCT04874506
Treatments Being Tested